Stevanato Group S.p.A (STVN) Stock Forecast: StockMap's 2-Week Call
STVN stock forecast: StockMap's model leans Outperform on Stevanato Group S.p.A for the two weeks after the Nov 19 close, toward STVN doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Too few two-week windows graded to judge yet.
Stevanato Group S.p.A last closed at $15.93, +3.71% on the session.
Against the IVW growth benchmark the position is +6.04% over the forecast window.
Stevanato Group S.p.A's market cap is $4.82B as of November 19, 2026.
Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 27 (too close to call).
Where STVN sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 8 bullish and 7 bearish.
Agreement across those insights is 53%.
15 daily calls for STVN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Stevanato Group S.p.A in the 31st percentile on valuation and the 57th percentile on return on equity, where 100 is best.
Stevanato Group S.p.A is classified under Health Care / Life Sciences Tools & Services.
StockMap tracks Stevanato Group S.p.A as the 21st largest of the 42 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 23 Neutral, 16 Moderate Outperform and 3 Moderate Underperform.
On that composite Stevanato Group S.p.A ranks 11th of 42 in the group, against a group median of +0.13.